Paydirt
ML
Insider

M33 Growth I GP LLC

Director

M33 Growth I GP LLC (Director) filed 3 Form 4 reports as a reporting entity in the past 24 months (0 purchases, 3 sales), most often in Starling Oncology Inc (TOI). The largest single filing was $20.7M of TOI (6,700,000 sh across 2 lots, as filed), executed Sep 4 2025.

Add to watchlist
Return, ttmiAverage return per filing, trailing twelve months
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
returns measure stock purchases only
Filings, ttm
3
0 buys · 3 sells
Median delay
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$28.4M
shares × price, as filed
Last traded
Sep 4 2025
Filed Sep 5 2025

Median ADV $10.2M across their filed names

Open performance
Volume by month
$20.7M$10.4M$0Oct 2024Apr 2025Oct 2025Apr 2026May 2025 · sells $5.4MJun 2025 · sells $2.3MSep 2025 · sells $20.7M
Buys $0 Sells $28.4M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on
Healthcare 3 filings

Sector per market data · by filing · past 24 months

Most traded names
TOI Starling Oncology Inc TOI · 0 buys · 3 sells 3 filings
Recent filings
TOISALE Starling Oncology Inc View filing → $20.7M
6,700,000 sh across 2 lots
Exec Sep 4 2025
Filed Sep 5 2025 · 5:30 PM ET
TOISALE Starling Oncology Inc View filing → $2.3M
750,000 sh across 2 lots
Exec Jun 5 2025
Filed Jun 9 2025 · 5:30 PM ET
TOISALE Starling Oncology Inc View filing → $5.4M
2,000,000 sh across 2 lots
Exec May 20 2025
Filed May 22 2025 · 5:30 PM ET